Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Restructuring Costs (2025)

Tandem Diabetes Care (TNDM) has disclosed Restructuring Costs for 1 consecutive years, with $20.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Restructuring Costs changed N/A year-over-year to $20.0 million, compared with a TTM value of $20.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $20.0 million, changed N/A over the prior year.
  • Restructuring Costs was $20.0 million for Q2 2025 at Tandem Diabetes Care.
  • Across five years, Restructuring Costs topped out at $20.0 million in Q2 2025 and bottomed at $20.0 million in Q2 2025.